Global Parkinsons Disease Drug Market Research Report 2024(Status and Outlook)
Report Overview:
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The Global Parkinsons Disease Drug Market Size was estimated at USD 5775.68 million in 2023 and is projected to reach USD 7435.48 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Parkinsons Disease Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinsons Disease Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinsons Disease Drug market in any manner.
Global Parkinsons Disease Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Market Segmentation (by Type)
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market Segmentation (by Application)
Hospital
Clinics
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinsons Disease Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The Global Parkinsons Disease Drug Market Size was estimated at USD 5775.68 million in 2023 and is projected to reach USD 7435.48 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
This report provides a deep insight into the global Parkinsons Disease Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinsons Disease Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinsons Disease Drug market in any manner.
Global Parkinsons Disease Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Novartis AG
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax Laboratories
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Market Segmentation (by Type)
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Market Segmentation (by Application)
Hospital
Clinics
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Parkinsons Disease Drug Market
- Overview of the regional outlook of the Parkinsons Disease Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinsons Disease Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Parkinsons Disease Drug
1.2 Key Market Segments
1.2.1 Parkinsons Disease Drug Segment by Type
1.2.2 Parkinsons Disease Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSONS DISEASE DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinsons Disease Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinsons Disease Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSONS DISEASE DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinsons Disease Drug Sales by Manufacturers (2019-2024)
3.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinsons Disease Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinsons Disease Drug Sales Sites, Area Served, Product Type
3.6 Parkinsons Disease Drug Market Competitive Situation and Trends
3.6.1 Parkinsons Disease Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinsons Disease Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSONS DISEASE DRUG INDUSTRY CHAIN ANALYSIS
4.1 Parkinsons Disease Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSONS DISEASE DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSONS DISEASE DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinsons Disease Drug Sales Market Share by Type (2019-2024)
6.3 Global Parkinsons Disease Drug Market Size Market Share by Type (2019-2024)
6.4 Global Parkinsons Disease Drug Price by Type (2019-2024)
7 PARKINSONS DISEASE DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinsons Disease Drug Market Sales by Application (2019-2024)
7.3 Global Parkinsons Disease Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2024)
8 PARKINSONS DISEASE DRUG MARKET SEGMENTATION BY REGION
8.1 Global Parkinsons Disease Drug Sales by Region
8.1.1 Global Parkinsons Disease Drug Sales by Region
8.1.2 Global Parkinsons Disease Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinsons Disease Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinsons Disease Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinsons Disease Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinsons Disease Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinsons Disease Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Parkinsons Disease Drug Basic Information
9.1.2 Teva Parkinsons Disease Drug Product Overview
9.1.3 Teva Parkinsons Disease Drug Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Parkinsons Disease Drug SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Novartis AG
9.2.1 Novartis AG Parkinsons Disease Drug Basic Information
9.2.2 Novartis AG Parkinsons Disease Drug Product Overview
9.2.3 Novartis AG Parkinsons Disease Drug Product Market Performance
9.2.4 Novartis AG Business Overview
9.2.5 Novartis AG Parkinsons Disease Drug SWOT Analysis
9.2.6 Novartis AG Recent Developments
9.3 GSK
9.3.1 GSK Parkinsons Disease Drug Basic Information
9.3.2 GSK Parkinsons Disease Drug Product Overview
9.3.3 GSK Parkinsons Disease Drug Product Market Performance
9.3.4 GSK Parkinsons Disease Drug SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 AbbVie
9.4.1 AbbVie Parkinsons Disease Drug Basic Information
9.4.2 AbbVie Parkinsons Disease Drug Product Overview
9.4.3 AbbVie Parkinsons Disease Drug Product Market Performance
9.4.4 AbbVie Business Overview
9.4.5 AbbVie Recent Developments
9.5 Merck
9.5.1 Merck Parkinsons Disease Drug Basic Information
9.5.2 Merck Parkinsons Disease Drug Product Overview
9.5.3 Merck Parkinsons Disease Drug Product Market Performance
9.5.4 Merck Business Overview
9.5.5 Merck Recent Developments
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Parkinsons Disease Drug Basic Information
9.6.2 Boehringer Ingelheim Parkinsons Disease Drug Product Overview
9.6.3 Boehringer Ingelheim Parkinsons Disease Drug Product Market Performance
9.6.4 Boehringer Ingelheim Business Overview
9.6.5 Boehringer Ingelheim Recent Developments
9.7 Impax Laboratories
9.7.1 Impax Laboratories Parkinsons Disease Drug Basic Information
9.7.2 Impax Laboratories Parkinsons Disease Drug Product Overview
9.7.3 Impax Laboratories Parkinsons Disease Drug Product Market Performance
9.7.4 Impax Laboratories Business Overview
9.7.5 Impax Laboratories Recent Developments
9.8 Lundbeck
9.8.1 Lundbeck Parkinsons Disease Drug Basic Information
9.8.2 Lundbeck Parkinsons Disease Drug Product Overview
9.8.3 Lundbeck Parkinsons Disease Drug Product Market Performance
9.8.4 Lundbeck Business Overview
9.8.5 Lundbeck Recent Developments
9.9 Sun Pharma
9.9.1 Sun Pharma Parkinsons Disease Drug Basic Information
9.9.2 Sun Pharma Parkinsons Disease Drug Product Overview
9.9.3 Sun Pharma Parkinsons Disease Drug Product Market Performance
9.9.4 Sun Pharma Business Overview
9.9.5 Sun Pharma Recent Developments
9.10 Wockhardt
9.10.1 Wockhardt Parkinsons Disease Drug Basic Information
9.10.2 Wockhardt Parkinsons Disease Drug Product Overview
9.10.3 Wockhardt Parkinsons Disease Drug Product Market Performance
9.10.4 Wockhardt Business Overview
9.10.5 Wockhardt Recent Developments
9.11 UCB
9.11.1 UCB Parkinsons Disease Drug Basic Information
9.11.2 UCB Parkinsons Disease Drug Product Overview
9.11.3 UCB Parkinsons Disease Drug Product Market Performance
9.11.4 UCB Business Overview
9.11.5 UCB Recent Developments
9.12 Bausch Health
9.12.1 Bausch Health Parkinsons Disease Drug Basic Information
9.12.2 Bausch Health Parkinsons Disease Drug Product Overview
9.12.3 Bausch Health Parkinsons Disease Drug Product Market Performance
9.12.4 Bausch Health Business Overview
9.12.5 Bausch Health Recent Developments
9.13 Acadia
9.13.1 Acadia Parkinsons Disease Drug Basic Information
9.13.2 Acadia Parkinsons Disease Drug Product Overview
9.13.3 Acadia Parkinsons Disease Drug Product Market Performance
9.13.4 Acadia Business Overview
9.13.5 Acadia Recent Developments
10 PARKINSONS DISEASE DRUG MARKET FORECAST BY REGION
10.1 Global Parkinsons Disease Drug Market Size Forecast
10.2 Global Parkinsons Disease Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinsons Disease Drug Market Size Forecast by Country
10.2.3 Asia Pacific Parkinsons Disease Drug Market Size Forecast by Region
10.2.4 South America Parkinsons Disease Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinsons Disease Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinsons Disease Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinsons Disease Drug by Type (2025-2030)
11.1.2 Global Parkinsons Disease Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinsons Disease Drug by Type (2025-2030)
11.2 Global Parkinsons Disease Drug Market Forecast by Application (2025-2030)
11.2.1 Global Parkinsons Disease Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Parkinsons Disease Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Parkinsons Disease Drug
1.2 Key Market Segments
1.2.1 Parkinsons Disease Drug Segment by Type
1.2.2 Parkinsons Disease Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PARKINSONS DISEASE DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Parkinsons Disease Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinsons Disease Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PARKINSONS DISEASE DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Parkinsons Disease Drug Sales by Manufacturers (2019-2024)
3.2 Global Parkinsons Disease Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinsons Disease Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinsons Disease Drug Sales Sites, Area Served, Product Type
3.6 Parkinsons Disease Drug Market Competitive Situation and Trends
3.6.1 Parkinsons Disease Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinsons Disease Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PARKINSONS DISEASE DRUG INDUSTRY CHAIN ANALYSIS
4.1 Parkinsons Disease Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PARKINSONS DISEASE DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PARKINSONS DISEASE DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinsons Disease Drug Sales Market Share by Type (2019-2024)
6.3 Global Parkinsons Disease Drug Market Size Market Share by Type (2019-2024)
6.4 Global Parkinsons Disease Drug Price by Type (2019-2024)
7 PARKINSONS DISEASE DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinsons Disease Drug Market Sales by Application (2019-2024)
7.3 Global Parkinsons Disease Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2024)
8 PARKINSONS DISEASE DRUG MARKET SEGMENTATION BY REGION
8.1 Global Parkinsons Disease Drug Sales by Region
8.1.1 Global Parkinsons Disease Drug Sales by Region
8.1.2 Global Parkinsons Disease Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinsons Disease Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinsons Disease Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinsons Disease Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinsons Disease Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinsons Disease Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Teva
9.1.1 Teva Parkinsons Disease Drug Basic Information
9.1.2 Teva Parkinsons Disease Drug Product Overview
9.1.3 Teva Parkinsons Disease Drug Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Parkinsons Disease Drug SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Novartis AG
9.2.1 Novartis AG Parkinsons Disease Drug Basic Information
9.2.2 Novartis AG Parkinsons Disease Drug Product Overview
9.2.3 Novartis AG Parkinsons Disease Drug Product Market Performance
9.2.4 Novartis AG Business Overview
9.2.5 Novartis AG Parkinsons Disease Drug SWOT Analysis
9.2.6 Novartis AG Recent Developments
9.3 GSK
9.3.1 GSK Parkinsons Disease Drug Basic Information
9.3.2 GSK Parkinsons Disease Drug Product Overview
9.3.3 GSK Parkinsons Disease Drug Product Market Performance
9.3.4 GSK Parkinsons Disease Drug SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 AbbVie
9.4.1 AbbVie Parkinsons Disease Drug Basic Information
9.4.2 AbbVie Parkinsons Disease Drug Product Overview
9.4.3 AbbVie Parkinsons Disease Drug Product Market Performance
9.4.4 AbbVie Business Overview
9.4.5 AbbVie Recent Developments
9.5 Merck
9.5.1 Merck Parkinsons Disease Drug Basic Information
9.5.2 Merck Parkinsons Disease Drug Product Overview
9.5.3 Merck Parkinsons Disease Drug Product Market Performance
9.5.4 Merck Business Overview
9.5.5 Merck Recent Developments
9.6 Boehringer Ingelheim
9.6.1 Boehringer Ingelheim Parkinsons Disease Drug Basic Information
9.6.2 Boehringer Ingelheim Parkinsons Disease Drug Product Overview
9.6.3 Boehringer Ingelheim Parkinsons Disease Drug Product Market Performance
9.6.4 Boehringer Ingelheim Business Overview
9.6.5 Boehringer Ingelheim Recent Developments
9.7 Impax Laboratories
9.7.1 Impax Laboratories Parkinsons Disease Drug Basic Information
9.7.2 Impax Laboratories Parkinsons Disease Drug Product Overview
9.7.3 Impax Laboratories Parkinsons Disease Drug Product Market Performance
9.7.4 Impax Laboratories Business Overview
9.7.5 Impax Laboratories Recent Developments
9.8 Lundbeck
9.8.1 Lundbeck Parkinsons Disease Drug Basic Information
9.8.2 Lundbeck Parkinsons Disease Drug Product Overview
9.8.3 Lundbeck Parkinsons Disease Drug Product Market Performance
9.8.4 Lundbeck Business Overview
9.8.5 Lundbeck Recent Developments
9.9 Sun Pharma
9.9.1 Sun Pharma Parkinsons Disease Drug Basic Information
9.9.2 Sun Pharma Parkinsons Disease Drug Product Overview
9.9.3 Sun Pharma Parkinsons Disease Drug Product Market Performance
9.9.4 Sun Pharma Business Overview
9.9.5 Sun Pharma Recent Developments
9.10 Wockhardt
9.10.1 Wockhardt Parkinsons Disease Drug Basic Information
9.10.2 Wockhardt Parkinsons Disease Drug Product Overview
9.10.3 Wockhardt Parkinsons Disease Drug Product Market Performance
9.10.4 Wockhardt Business Overview
9.10.5 Wockhardt Recent Developments
9.11 UCB
9.11.1 UCB Parkinsons Disease Drug Basic Information
9.11.2 UCB Parkinsons Disease Drug Product Overview
9.11.3 UCB Parkinsons Disease Drug Product Market Performance
9.11.4 UCB Business Overview
9.11.5 UCB Recent Developments
9.12 Bausch Health
9.12.1 Bausch Health Parkinsons Disease Drug Basic Information
9.12.2 Bausch Health Parkinsons Disease Drug Product Overview
9.12.3 Bausch Health Parkinsons Disease Drug Product Market Performance
9.12.4 Bausch Health Business Overview
9.12.5 Bausch Health Recent Developments
9.13 Acadia
9.13.1 Acadia Parkinsons Disease Drug Basic Information
9.13.2 Acadia Parkinsons Disease Drug Product Overview
9.13.3 Acadia Parkinsons Disease Drug Product Market Performance
9.13.4 Acadia Business Overview
9.13.5 Acadia Recent Developments
10 PARKINSONS DISEASE DRUG MARKET FORECAST BY REGION
10.1 Global Parkinsons Disease Drug Market Size Forecast
10.2 Global Parkinsons Disease Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinsons Disease Drug Market Size Forecast by Country
10.2.3 Asia Pacific Parkinsons Disease Drug Market Size Forecast by Region
10.2.4 South America Parkinsons Disease Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinsons Disease Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Parkinsons Disease Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinsons Disease Drug by Type (2025-2030)
11.1.2 Global Parkinsons Disease Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinsons Disease Drug by Type (2025-2030)
11.2 Global Parkinsons Disease Drug Market Forecast by Application (2025-2030)
11.2.1 Global Parkinsons Disease Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Parkinsons Disease Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinsons Disease Drug Market Size Comparison by Region (M USD)
Table 5. Global Parkinsons Disease Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinsons Disease Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2022)
Table 10. Global Market Parkinsons Disease Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinsons Disease Drug Sales Sites and Area Served
Table 12. Manufacturers Parkinsons Disease Drug Product Type
Table 13. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinsons Disease Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinsons Disease Drug Market Challenges
Table 22. Global Parkinsons Disease Drug Sales by Type (Kilotons)
Table 23. Global Parkinsons Disease Drug Market Size by Type (M USD)
Table 24. Global Parkinsons Disease Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Parkinsons Disease Drug Sales Market Share by Type (2019-2024)
Table 26. Global Parkinsons Disease Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinsons Disease Drug Market Size Share by Type (2019-2024)
Table 28. Global Parkinsons Disease Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Parkinsons Disease Drug Sales (Kilotons) by Application
Table 30. Global Parkinsons Disease Drug Market Size by Application
Table 31. Global Parkinsons Disease Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2024)
Table 33. Global Parkinsons Disease Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinsons Disease Drug Market Share by Application (2019-2024)
Table 35. Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinsons Disease Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2024)
Table 38. North America Parkinsons Disease Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Parkinsons Disease Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Parkinsons Disease Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Parkinsons Disease Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Parkinsons Disease Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Parkinsons Disease Drug Basic Information
Table 44. Teva Parkinsons Disease Drug Product Overview
Table 45. Teva Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Parkinsons Disease Drug SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Novartis AG Parkinsons Disease Drug Basic Information
Table 50. Novartis AG Parkinsons Disease Drug Product Overview
Table 51. Novartis AG Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Parkinsons Disease Drug SWOT Analysis
Table 54. Novartis AG Recent Developments
Table 55. GSK Parkinsons Disease Drug Basic Information
Table 56. GSK Parkinsons Disease Drug Product Overview
Table 57. GSK Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Parkinsons Disease Drug SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. AbbVie Parkinsons Disease Drug Basic Information
Table 62. AbbVie Parkinsons Disease Drug Product Overview
Table 63. AbbVie Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AbbVie Business Overview
Table 65. AbbVie Recent Developments
Table 66. Merck Parkinsons Disease Drug Basic Information
Table 67. Merck Parkinsons Disease Drug Product Overview
Table 68. Merck Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merck Business Overview
Table 70. Merck Recent Developments
Table 71. Boehringer Ingelheim Parkinsons Disease Drug Basic Information
Table 72. Boehringer Ingelheim Parkinsons Disease Drug Product Overview
Table 73. Boehringer Ingelheim Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Recent Developments
Table 76. Impax Laboratories Parkinsons Disease Drug Basic Information
Table 77. Impax Laboratories Parkinsons Disease Drug Product Overview
Table 78. Impax Laboratories Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Impax Laboratories Business Overview
Table 80. Impax Laboratories Recent Developments
Table 81. Lundbeck Parkinsons Disease Drug Basic Information
Table 82. Lundbeck Parkinsons Disease Drug Product Overview
Table 83. Lundbeck Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lundbeck Business Overview
Table 85. Lundbeck Recent Developments
Table 86. Sun Pharma Parkinsons Disease Drug Basic Information
Table 87. Sun Pharma Parkinsons Disease Drug Product Overview
Table 88. Sun Pharma Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sun Pharma Business Overview
Table 90. Sun Pharma Recent Developments
Table 91. Wockhardt Parkinsons Disease Drug Basic Information
Table 92. Wockhardt Parkinsons Disease Drug Product Overview
Table 93. Wockhardt Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Wockhardt Business Overview
Table 95. Wockhardt Recent Developments
Table 96. UCB Parkinsons Disease Drug Basic Information
Table 97. UCB Parkinsons Disease Drug Product Overview
Table 98. UCB Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. UCB Business Overview
Table 100. UCB Recent Developments
Table 101. Bausch Health Parkinsons Disease Drug Basic Information
Table 102. Bausch Health Parkinsons Disease Drug Product Overview
Table 103. Bausch Health Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bausch Health Business Overview
Table 105. Bausch Health Recent Developments
Table 106. Acadia Parkinsons Disease Drug Basic Information
Table 107. Acadia Parkinsons Disease Drug Product Overview
Table 108. Acadia Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Acadia Business Overview
Table 110. Acadia Recent Developments
Table 111. Global Parkinsons Disease Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Parkinsons Disease Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Parkinsons Disease Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Parkinsons Disease Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Parkinsons Disease Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Parkinsons Disease Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Parkinsons Disease Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Parkinsons Disease Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Parkinsons Disease Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Parkinsons Disease Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Parkinsons Disease Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Parkinsons Disease Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Parkinsons Disease Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parkinsons Disease Drug Market Size Comparison by Region (M USD)
Table 5. Global Parkinsons Disease Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Parkinsons Disease Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parkinsons Disease Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parkinsons Disease Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinsons Disease Drug as of 2022)
Table 10. Global Market Parkinsons Disease Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parkinsons Disease Drug Sales Sites and Area Served
Table 12. Manufacturers Parkinsons Disease Drug Product Type
Table 13. Global Parkinsons Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parkinsons Disease Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parkinsons Disease Drug Market Challenges
Table 22. Global Parkinsons Disease Drug Sales by Type (Kilotons)
Table 23. Global Parkinsons Disease Drug Market Size by Type (M USD)
Table 24. Global Parkinsons Disease Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Parkinsons Disease Drug Sales Market Share by Type (2019-2024)
Table 26. Global Parkinsons Disease Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Parkinsons Disease Drug Market Size Share by Type (2019-2024)
Table 28. Global Parkinsons Disease Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Parkinsons Disease Drug Sales (Kilotons) by Application
Table 30. Global Parkinsons Disease Drug Market Size by Application
Table 31. Global Parkinsons Disease Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2024)
Table 33. Global Parkinsons Disease Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Parkinsons Disease Drug Market Share by Application (2019-2024)
Table 35. Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Parkinsons Disease Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2024)
Table 38. North America Parkinsons Disease Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Parkinsons Disease Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Parkinsons Disease Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Parkinsons Disease Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Parkinsons Disease Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Teva Parkinsons Disease Drug Basic Information
Table 44. Teva Parkinsons Disease Drug Product Overview
Table 45. Teva Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Parkinsons Disease Drug SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Novartis AG Parkinsons Disease Drug Basic Information
Table 50. Novartis AG Parkinsons Disease Drug Product Overview
Table 51. Novartis AG Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis AG Business Overview
Table 53. Novartis AG Parkinsons Disease Drug SWOT Analysis
Table 54. Novartis AG Recent Developments
Table 55. GSK Parkinsons Disease Drug Basic Information
Table 56. GSK Parkinsons Disease Drug Product Overview
Table 57. GSK Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. GSK Parkinsons Disease Drug SWOT Analysis
Table 59. GSK Business Overview
Table 60. GSK Recent Developments
Table 61. AbbVie Parkinsons Disease Drug Basic Information
Table 62. AbbVie Parkinsons Disease Drug Product Overview
Table 63. AbbVie Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AbbVie Business Overview
Table 65. AbbVie Recent Developments
Table 66. Merck Parkinsons Disease Drug Basic Information
Table 67. Merck Parkinsons Disease Drug Product Overview
Table 68. Merck Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merck Business Overview
Table 70. Merck Recent Developments
Table 71. Boehringer Ingelheim Parkinsons Disease Drug Basic Information
Table 72. Boehringer Ingelheim Parkinsons Disease Drug Product Overview
Table 73. Boehringer Ingelheim Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Recent Developments
Table 76. Impax Laboratories Parkinsons Disease Drug Basic Information
Table 77. Impax Laboratories Parkinsons Disease Drug Product Overview
Table 78. Impax Laboratories Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Impax Laboratories Business Overview
Table 80. Impax Laboratories Recent Developments
Table 81. Lundbeck Parkinsons Disease Drug Basic Information
Table 82. Lundbeck Parkinsons Disease Drug Product Overview
Table 83. Lundbeck Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Lundbeck Business Overview
Table 85. Lundbeck Recent Developments
Table 86. Sun Pharma Parkinsons Disease Drug Basic Information
Table 87. Sun Pharma Parkinsons Disease Drug Product Overview
Table 88. Sun Pharma Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sun Pharma Business Overview
Table 90. Sun Pharma Recent Developments
Table 91. Wockhardt Parkinsons Disease Drug Basic Information
Table 92. Wockhardt Parkinsons Disease Drug Product Overview
Table 93. Wockhardt Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Wockhardt Business Overview
Table 95. Wockhardt Recent Developments
Table 96. UCB Parkinsons Disease Drug Basic Information
Table 97. UCB Parkinsons Disease Drug Product Overview
Table 98. UCB Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. UCB Business Overview
Table 100. UCB Recent Developments
Table 101. Bausch Health Parkinsons Disease Drug Basic Information
Table 102. Bausch Health Parkinsons Disease Drug Product Overview
Table 103. Bausch Health Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bausch Health Business Overview
Table 105. Bausch Health Recent Developments
Table 106. Acadia Parkinsons Disease Drug Basic Information
Table 107. Acadia Parkinsons Disease Drug Product Overview
Table 108. Acadia Parkinsons Disease Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Acadia Business Overview
Table 110. Acadia Recent Developments
Table 111. Global Parkinsons Disease Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Parkinsons Disease Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Parkinsons Disease Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Parkinsons Disease Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Parkinsons Disease Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Parkinsons Disease Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Parkinsons Disease Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Parkinsons Disease Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Parkinsons Disease Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Parkinsons Disease Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Parkinsons Disease Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Parkinsons Disease Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Parkinsons Disease Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Parkinsons Disease Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Parkinsons Disease Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinsons Disease Drug Market Size (M USD), 2019-2030
Figure 5. Global Parkinsons Disease Drug Market Size (M USD) (2019-2030)
Figure 6. Global Parkinsons Disease Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinsons Disease Drug Market Size by Country (M USD)
Figure 11. Parkinsons Disease Drug Sales Share by Manufacturers in 2023
Figure 12. Global Parkinsons Disease Drug Revenue Share by Manufacturers in 2023
Figure 13. Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinsons Disease Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinsons Disease Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinsons Disease Drug Market Share by Type
Figure 18. Sales Market Share of Parkinsons Disease Drug by Type (2019-2024)
Figure 19. Sales Market Share of Parkinsons Disease Drug by Type in 2023
Figure 20. Market Size Share of Parkinsons Disease Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinsons Disease Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinsons Disease Drug Market Share by Application
Figure 24. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinsons Disease Drug Sales Market Share by Application in 2023
Figure 26. Global Parkinsons Disease Drug Market Share by Application (2019-2024)
Figure 27. Global Parkinsons Disease Drug Market Share by Application in 2023
Figure 28. Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 32. U.S. Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Parkinsons Disease Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinsons Disease Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 37. Germany Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Parkinsons Disease Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Parkinsons Disease Drug Sales Market Share by Region in 2023
Figure 44. China Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Parkinsons Disease Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 51. Brazil Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Parkinsons Disease Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Parkinsons Disease Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Parkinsons Disease Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinsons Disease Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinsons Disease Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinsons Disease Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinsons Disease Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Parkinsons Disease Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parkinsons Disease Drug Market Size (M USD), 2019-2030
Figure 5. Global Parkinsons Disease Drug Market Size (M USD) (2019-2030)
Figure 6. Global Parkinsons Disease Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parkinsons Disease Drug Market Size by Country (M USD)
Figure 11. Parkinsons Disease Drug Sales Share by Manufacturers in 2023
Figure 12. Global Parkinsons Disease Drug Revenue Share by Manufacturers in 2023
Figure 13. Parkinsons Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parkinsons Disease Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parkinsons Disease Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parkinsons Disease Drug Market Share by Type
Figure 18. Sales Market Share of Parkinsons Disease Drug by Type (2019-2024)
Figure 19. Sales Market Share of Parkinsons Disease Drug by Type in 2023
Figure 20. Market Size Share of Parkinsons Disease Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Parkinsons Disease Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parkinsons Disease Drug Market Share by Application
Figure 24. Global Parkinsons Disease Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Parkinsons Disease Drug Sales Market Share by Application in 2023
Figure 26. Global Parkinsons Disease Drug Market Share by Application (2019-2024)
Figure 27. Global Parkinsons Disease Drug Market Share by Application in 2023
Figure 28. Global Parkinsons Disease Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parkinsons Disease Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 32. U.S. Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Parkinsons Disease Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Parkinsons Disease Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 37. Germany Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Parkinsons Disease Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Parkinsons Disease Drug Sales Market Share by Region in 2023
Figure 44. China Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Parkinsons Disease Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Parkinsons Disease Drug Sales Market Share by Country in 2023
Figure 51. Brazil Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Parkinsons Disease Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Parkinsons Disease Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Parkinsons Disease Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Parkinsons Disease Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Parkinsons Disease Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Parkinsons Disease Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Parkinsons Disease Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Parkinsons Disease Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Parkinsons Disease Drug Market Share Forecast by Application (2025-2030)
